Henry Schein, Inc. (LON:0L3C)

London flag London · Delayed Price · Currency is GBP · Price in USD
76.18
-1.38 (-1.77%)
Dec 24, 2025, 2:30 PM BST
8.32%
Market Cap6.65B
Revenue (ttm)9.65B
Net Income (ttm)291.56M
Shares Outn/a
EPS (ttm)2.36
PE Ratio22.79
Forward PE14.46
Dividendn/a
Ex-Dividend Daten/a
Volume476
Average Volume710
Open76.18
Previous Close77.55
Day's Range76.18 - 76.18
52-Week Range60.80 - 82.31
Beta0.89
RSI58.11
Earnings DateFeb 25, 2026

About Henry Schein

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chair... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1932
Employees 25,000
Stock Exchange London Stock Exchange
Ticker Symbol 0L3C
Full Company Profile

Financial Performance

In 2024, Henry Schein's revenue was $12.67 billion, an increase of 2.71% compared to the previous year's $12.34 billion. Earnings were $390.00 million, a decrease of -6.25%.

Financial numbers in USD Financial Statements

News

Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement

Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement

19 days ago - GuruFocus

Barclays Initiates Coverage on HSIC with Overweight Rating | HSIC Stock News

Barclays Initiates Coverage on HSIC with Overweight Rating | HSIC Stock News

19 days ago - GuruFocus

Henry Schein Can Make Your Portfolio Smile

Henry Schein, Inc. is rated a Buy with solid growth, strong Q3 revenue & improved profitability across all segments. Learn more about HSIC stock here.

23 days ago - Seeking Alpha

Henry Schein Inc at Piper Sandler Healthcare Conference Transcript

Henry Schein Inc at Piper Sandler Healthcare Conference Transcript

26 days ago - GuruFocus

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

26 days ago - Seeking Alpha

HSIC Stock Benefits From Expanded Partnership With vVARDIS

Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.

26 days ago - Nasdaq

Henry Schein Expands Partnership with vVARDIS

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the dril...

27 days ago - Business Wire

HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch

HSIC gains momentum as Henry Schein One rolls out AI-powered dental workflows unveiled at the Greater New York Dental Meeting.

27 days ago - Nasdaq

Artisan Select Equity Fund Q3 2025 Portfolio Review

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung...

4 weeks ago - Seeking Alpha

Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting

AMERICAN FORK, Utah--(BUSINESS WIRE)--Coming off the heels of its announcement with Amazon Web Services, Henry Schein One, the leading provider of global dental technology, today unveils natively embe...

4 weeks ago - Business Wire

Peering Into Henry Schein Inc's Recent Short Interest

Henry Schein Inc's (NYSE: HSIC) short interest as a percent of float has fallen 4.94% since its last report. According to exchange reported data, there are now 8.38 million shares sold short , which ...

4 weeks ago - Benzinga

American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as p...

5 weeks ago - Seeking Alpha

Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript

Henry Schein, Inc. (HSIC) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM ESTCompany ParticipantsStanley Bergman - Executive Chairman...

5 weeks ago - Seeking Alpha

Worried About an AI Bubble? Here Are BofA's Top Stock Picks to Diversify Your Portfolio

If you're looking to diversify your stock portfolio away from AI, Bank of America has some suggestions.

6 weeks ago - Investopedia

Henry Schein to Participate in Upcoming Investor Conference in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Com...

6 weeks ago - Business Wire

Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too?

Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too?

6 weeks ago - The Motley Fool

KKR Moves To Take Japan's Forum Engineering Private

On Monday, KKR & Co. Inc. (NYSE: KKR) disclosed the plan to launch a tender offer for Japan-based company, Forum Engineering Inc. , through its subsidiary KJ003 Co., Ltd., owned by KKR-managed funds ...

6 weeks ago - Benzinga

JPMorgan Chase & Co. Reduces Stake in Henry Schein Inc.

JPMorgan Chase & Co. Reduces Stake in Henry Schein Inc.

7 weeks ago - GuruFocus

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On CNBC's “ Mad Money Lightning Round ,” Jim Cramer said Chipotle Mexican Grill, Inc. (NYSE: CMG) is “too expensive.” Chipotle, on Oct. 29, reported quarterly earnings of 29 cents per share, in line ...

7 weeks ago - Benzinga

HSIC: JP Morgan Raises Price Target to $78. ...

HSIC: JP Morgan Raises Price Target to $78.00 While Maintaining "Overweight" Rating | HSIC Stock News

7 weeks ago - GuruFocus

Henry Schein (HSIC) Sees Price Target Raised to $79 by Barrington Research | HSIC Stock News

Henry Schein (HSIC) Sees Price Target Raised to $79 by Barrington Research | HSIC Stock News

7 weeks ago - GuruFocus

Morgan Stanley Maintains 'Underweight' Rating, Raises Price Target for HSIC | HSIC Stock News

Morgan Stanley Maintains 'Underweight' Rating, Raises Price Target for HSIC | HSIC Stock News

7 weeks ago - GuruFocus

HSIC November 2026 Options Begin Trading

Investors in Henry Schein Inc (Symbol: HSIC) saw new options become available today, for the November 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...

7 weeks ago - Nasdaq

HSIC Stock Gets Price Target Boost from Wells Fargo | HSIC Stock News

HSIC Stock Gets Price Target Boost from Wells Fargo | HSIC Stock News

7 weeks ago - GuruFocus